Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells
A versatile and modular platform that enables programmable control of CAR T-cell activity is reported, offering a new strategy to overcome tumor heterogeneity and immune suppression.